NYU Dentistry’s Pain Research Center receives $8M NIH grant to study oral cancer pain

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Researchers at NYU Dentistry’s Pain Research Center have been awarded a five-year, $8 million NIH grant to study signaling mechanisms that generate oral cancer pain. The funding is part of the NIH’s Helping to End Addiction Long-term Initiative, which supports the development of safe and effective therapeutics to treat pain in an effort to end the opioid crisis.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Epidermal growth factor receptor signaling in the tissue around oral cancers both increases nerve sensitivity and makes opioids less effective, according to a study conducted by researchers at NYU, MD Anderson, and Loma Linda University. The finding points to a shared mechanism underlying both oral cancer pain and opioid tolerance, and a possible new treatment strategy for both.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login